Advanced Cervical Cancer

8 clinical trials · Condition

Record	Firm	Date
A Clinical Trial to Evaluate Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignancy (NCT05068921)	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	2021-12-09
Combination Therapy for First Line Treatment of Advanced Cervical Cancer (NCT04731038)	Ruijin Hospital	2021-08-01
A Phase II Clinical Study to Assess the Efficacy and Safety of IBI310 or Placebo Combined With Sintilimab for Advanced Cervical Cancer Subjects Who Have Failed or Cannot Tolerate First-line or Above Platinum-based Chemotherapy (NCT04590599)	Innovent Biologics (Suzhou) Co. Ltd.	2020-12-08
Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 1) (NCT04508686)	Ruijin Hospital	2020-08-01
Study of ADXS11-001 in Participants With High Risk Locally Advanced Cervical Cancer (NCT02853604)	Advaxis, Inc.	2015-12-15
Molecular Biology Analysis for Para-aortic Nodes in the Ultra-staging of Advanced Cervical Cancers (NCT02888717)	Institut Cancerologie de l'Ouest	2015-04-28

Every clearance here is in the API, with alerts when new ones post.